Skip to main content
James Fagin, MD, Endocrinology, New York, NY

JamesAlexanderFaginMD

Endocrinology New York, NY

Diabetes, Lipid Metabolism, Thyroid

Head, Division of Subspecialty Medicine Memorial Sloan Kettering Cancer Center

Dr. Fagin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fagin's full profile

Already have an account?

  • Office

    530 East 74th Street
    New York, NY 10021

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985
  • University of Buenos Aires
    University of Buenos AiresClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - Present
  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2006 - 2026
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • OH State Medical License
    OH State Medical License 1995 - 2007
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians, 2001
  • Top Doctors: New York Metro Area Castle Connolly, 2014
  • Elected Member The American Society for Clinical Investigation, 1995

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers  
    Steven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism
  • Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated with Decreased Survival  
    James Fagin, MD, The Journal of Clinical Endocrinology and Metabolism
  • Methodology, Criteria and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts  
    James A Fagin, Stephen D Rohl, Robert C Smallridge, Stefan K Grebe, The Journal of Clinical Endocrinology and Metabolism

Lectures

  • Targeting Deregulated Signaling in Thyroid Cancer 
    ENDO 2019 - New Orleans, LA - 3/25/2019

Press Mentions

  • Novel Agent Nixes Radioiodine Resistance in Thyroid Cancer
    Novel Agent Nixes Radioiodine Resistance in Thyroid CancerOctober 7th, 2020
  • Bench to Bedside: Translating Science from the Lab to the Clinic
    Bench to Bedside: Translating Science from the Lab to the ClinicMay 2nd, 2019
  • 87th Annual Meeting News
    87th Annual Meeting NewsOctober 20th, 2017
  • Join now to see all

Grant Support

  • Oncogenic Events In Thyroid NeoplasiaNational Cancer Institute2006–2012
  • Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute2006–2012
  • A Validated Resource Of Thyroid Cancer Cell Lines For Pathway DiscoveryNational Cancer Institute2009–2010
  • Paracrine Igf/Gfbp Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
  • Paracrine Igf/Gfbp Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
  • Oncogenic Events In Thyroid NeoplasiaNational Cancer Institute1997–2006
  • Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute1995–2004
  • Biological And Physiological Sciences Review SectionCenter For Scientific Review2001–2002
  • Paracrine IGF/IGFBP Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
  • Molecular Pathophysiology Of Thyroid Cell GrowthNational Center For Research Resources2000–2001
  • N-Acetylcysteine As A Potential Treatment For Methamphetamine DependenceCenter For Scientific Review2000
  • Insulin LIKE Growth Factor I In Arterial Wall InjuryNational Heart, Lung, And Blood Institute1995–1996
  • Insulin LIKE Growth Factor I In Arterial Wall InjuryNational Heart, Lung, And Blood Institute1994
  • Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute1989–1993
  • Tumor Suppressor Genes In Human Thyroid NeoplasmsNational Cancer Institute1990
  • Human Growth Hormone-Secreting Hybrid CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1985–1986

Other Languages

  • Spanish